The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 25
- 25 new
- Median first-year cost
- $49,194
- $1,126,187 in all
- Institutions
- 25
- 25 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
25
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- DUKE UNIVERSITY1
- EMORY UNIVERSITY1
- GEORGETOWN UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
and 20 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 RPRB-7 (M1))25
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2023 | Fibroblasts in the establishment of the liver pre-metastatic niche1F99CA284357-01 | Ozaki, Michelle Kayoko | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Aging in place for older adults with cancer: The role of physical function and home environment1F99CA284180-01 | Jensen-Battaglia, Marielle | UNIVERSITY OF ROCHESTER, NY | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Multidomain Peptide Hydrogels as a Therapeutic Delivery Platform for Cancer Treatment1F99CA284262-01 | Pogostin, Brett | RICE UNIVERSITY, TX | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Transcriptome and spatial analyses of tumor environment in addressing colorectal cancer racial and ethnical disparities1F99CA284261-01 | Yin, Hang | UNIVERSITY OF WASHINGTON, WA | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Mechanisms of gene expression regulation in pancreatic cancer1F99CA284259-01 | Pease, David R | MAYO CLINIC ROCHESTER, MN | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM1F99CA284254-01 | Johnson, Amanda | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Identifying Inflammatory Mediators of Clonal Hematopoiesis1F99CA284253-01 | Fernandez Maestre, Ines | SLOAN-KETTERING INST CAN RESEARCH, NY | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Dissecting the role of mitochondrial glutathione homeostasis in cancer1F99CA284249-01 | Liu, Yuyang | ROCKEFELLER UNIVERSITY, NY | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Engineering Biomaterials to Modulate the Bone Marrow Microenvironment in Multiple Myeloma1F99CA284294-01 | Figueroa-Espada, Christian Gabriel | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Immune Regulation of Dormancy at the Metastatic Site1F99CA284292-01 | Han, Xiao | STATE UNIVERSITY NEW YORK STONY BROOK, NY | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study1F99CA284291-01 | Stal, Julia | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Chromatin and immune regulation of tumor growth and progression1F99CA284289-01 | Ashkin, Emily Lorin | STANFORD UNIVERSITY, CA | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis1F99CA284280-01 | Beitz, Adam Matthew | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Elucidating the role of mRNA m6A methylation in tumorigenesis1F99CA284279-01 | Wilkinson, Emma Anne | UNIVERSITY OF CHICAGO, IL | First-year cost $49,194 | Study section ZCA1 |
| FY2023 | Impact of neurofibromin on ER-alpha and nuclear speck post-transcriptional gene regulation1F99CA284282-01 | Dischinger, Patrick | VAN ANDEL RESEARCH INSTITUTE, MI | First-year cost $48,194 | Study section ZCA1 |
| FY2023 | Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells1F99CA284255-01 | Bennion, Kelsey | EMORY UNIVERSITY, GA | First-year cost $46,932 | Study section ZCA1 |
| FY2023 | Inter-organellar communication in metabolic reprogramming of colorectal cancer1F99CA284256-01 | Chen, Brandon | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $42,314 | Study section ZCA1 |
| FY2023 | Dissecting the intrinsic and extrinsic regulators of prostate cancer dormancy in the bonemicroenvironment.1F99CA284258-01 | Nasr, Mostafa M. | UNIVERSITY OF SOUTH FLORIDA, FL | First-year cost $41,193 | Study section ZCA1 |
| FY2023 | Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies1F99CA284283-01 | Sunassee, Enakshi D. | DUKE UNIVERSITY, NC | First-year cost $40,503 | Study section ZCA1 |
| FY2023 | Mechanisms and In Vivo Efficacy of Synergistic Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia1F99CA284252-01 | Ung, Johnson | UNIVERSITY OF VIRGINIA, VA | First-year cost $38,281 | Study section ZCA1 |
| FY2023 | Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer1F99CA284365-01 | Enriquez, Jose S | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $37,180 | Study section ZCA1 |
| FY2023 | Discerning mechanisms of semaphorin 7A-mediated tumor progression via immunoevasion1F99CA284276-01 | Elder, Alan Michael | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $36,666 | Study section ZCA1 |
| FY2023 | Targeting chemotherapy resistant high grade serous ovarian cancer1F99CA284284-01 | Ebrahimi, Behnam | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | First-year cost $36,520 | Study section ZCA1 |
| FY2023 | p27pTpT drives cancer-promoting inflammation and shapes the tumor microenvironment (TME) toward a more tumor-permissive state in vivo1F99CA284295-01 | Razavipour, Seyedehfatemeh | GEORGETOWN UNIVERSITY, DC | First-year cost $36,494 | Study section ZCA1 |
| FY2023 | Defining the role of chromosomal break end synapsis factors for DNA repair1F99CA284248-01 | Cisneros, Metztli | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | First-year cost $33,194 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.